Les tumeurs hépato-biliaires chez le chien et le chat (notice n° 762475)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03029cam a2200265 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123102945.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sayag, David |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Les tumeurs hépato-biliaires chez le chien et le chat |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 65 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Hepatobiliary tumors represent approximately 2 % of all neoplasms in dogs and cats, and can be primary (adenomas, hepatocarcinomas, cholangiocarcinomas, hemangiosarcomas, lymphomas, neuroendocrine tumours, etc.) or secondary to metastatic disease. The clinical signs are generally non-specific, although paraneoplastic hypoglycemia is rarely identified in practice. Imaging examinations, and in particular ultrasound and computed tomography, make it possible to identify a mass, nodules or a change in the appearance of the liver parenchyma. Definitive diagnosis is based on histopathological examination. Therapeutic strategies remain dependent on the subtype of the tumor and may include surgery (particularly in the mass form presentation), chemotherapy (particularly in lymphomas and mast cell tumors), targeted therapies, and radiation therapy. Interventional oncology (microwave ablation, chemoembolization) tends to offer new perspectives in the future management of these tumors. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Les tumeurs hépatobiliaires représentent approximativement 2 % de l’ensemble des néoplasies chez le chien et le chat, et peuvent être primitives (adénomes, hépatocarcinomes, cholangiocarcinomes, hémangiosarcomes, lymphomes, tumeurs neuroendocrines…) ou secondaires à une maladie métastatique. Les signes cliniques d’appel sont généralement non spécifiques, bien qu’une hypoglycémie paranéoplasique soit rarement identifiée en pratique. Les examens d’imagerie, et notamment l’échographie et la tomodensitométrie, permettent d’identifier une masse, des nodules ou une modification de l’aspect du parenchyme hépatique compatible avec une infiltration diffuse. Le diagnostic de certitude repose sur un examen histopathologique. Les stratégies thérapeutiques demeurent dépendantes de la nature primitive de la tumeur, et peuvent inclure la chirurgie (notamment lors de forme massique), la chimiothérapie (notamment dans les lymphomes et mastocytomes), les thérapies ciblées, et la radiothérapie. L’oncologie interventionnelle (ablation micro-ondes, chimio-embolisation) tend à offrir de nouvelles perspectives dans la prise en charge future de ces tumeurs. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cholangiocarcinome |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hépatocarcinome |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | lymphome hépatique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | métastase hépatique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hepatic lymphoma |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cholangiocarcinoma |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hepatic metastasis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hepatocarcinoma |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Le Nouveau Praticien Vétérinaire - Canine & féline | 20 | 2 | 2023-07-01 | p. 36-48 | 1637-3065 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-le-nouveau-praticien-veterinaire-canine-et-feline-2023-2-page-36?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-le-nouveau-praticien-veterinaire-canine-et-feline-2023-2-page-36?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux